Key result
Four out of six beta 2 glycoprotein I dependent anticardiolipin antibodies affinity purified from patients demonstrated lupus anticoagulant activity.
Some beta 2 glycoprotein I dependent anticardiolipin antibodies possess lupus anticoagulant activity, though the mechanism for this heterogeneity remains unclear.
Answers are grounded in this paper and cite their sources.
Some aCL antibodies exhibit LA activity; hypothesis-generating for APS mechanisms, requires human validation.
AIMS: To determine whether beta 2 glycoprotein I (beta 2GPI) dependent anticardiolipin (aCL) antibodies detected in solid phase enzyme linked immunosorbent assays can also have lupus anticoagulant activity. METHODS: Six anticardiolipin antibodies were affinity purified from patients with these antibodies and lupus anticoagulant activity in their plasma. RESULTS: The anticardiolipin antibodies bound only to anionic phospholipids in the presence of beta 2GPI and bound to beta 2GPI in the absence of phospholipids. Four out of six had lupus anticoagulant activity in the dilute Russell viper venom time test. CONCLUSIONS: The results show that some beta 2GPI dependent aCL are lupus anticoagulants. It is unclear why only some should have lupus anticoagulant activity while others do not.
No takes yet. Share an insight, caveat, or question.
Keeling et al. (1993) studied Lupus anticoagulant / Antiphospholipid antibodies (n=6). Beta 2 glycoprotein I dependent anticardiolipin antibodies was evaluated on Lupus anticoagulant activity in the dilute Russell viper venom time test. Four out of six beta 2 glycoprotein I dependent anticardiolipin antibodies affinity purified from patients demonstrated lupus anticoagulant activity.
Synapse has enriched 10 related papers. Consider them for comparative context: